Back to Search
GREGORY KELLER, M.D.
M.D.
Plastic Surgery Physician
NPI: 1699961474Individual
Specialties, Licenses & Credentials
Plastic and Reconstructive Surgery Physician
Surgery — Plastic and Reconstructive Surgery
Code: 2086S0122X
22919(CA)
Plastic Surgery PhysicianPrimary
Plastic Surgery
Code: 208200000X
G22919(CA)
Research & Publications (20)
Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
PMID 19569255·Hematol Oncol·2009
6-review
Experimental demonstration of frequency-degenerate bright EPR beams with a self-phase-locked OPO.
PMID 18575498·Opt Express·2008
8-other
Ability of pleth variability index to detect hemodynamic changes induced by passive leg raising in spontaneously breathing volunteers.
PMID 18325089·Crit Care·2008
8-other
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.
PMID 16801542·Proc Natl Acad Sci U S A·2006
7-preclinical
[Abdomina distention and edema due to spermatic cord cyst].
PMID 16715766·Medicina (B Aires)·2006
5-case
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins.
PMID 16685451·Int J Oncol·2006
7-preclinical
Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas.
PMID 16211544·Cancer·2005
4-observational
Growth inhibition of experimental non-Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN-238.
PMID 15609311·Int J Cancer·2005
7-preclinical
Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue.
PMID 15994963·Cancer Res·2005
7-preclinical
Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone.
PMID 16027368·Proc Natl Acad Sci U S A·2005
4-observational
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
PMID 16061872·Clin Cancer Res·2005
7-preclinical
Receptors for luteinizing hormone releasing hormone (LHRH) expressed in human non-Hodgkin's lymphomas can be targeted for therapy with the cytotoxic LHRH analogue AN-207.
PMID 16182122·Eur J Cancer·2005
7-preclinical
Reproductive effects and geographical distributions of two Wolbachia strains infecting the Neotropical beetle, Chelymorpha alternans Boh. (Chrysomelidae, Cassidinae).
PMID 15245413·Mol Ecol·2004
4-observational
Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
PMID 19474748·Eur J Gastroenterol Hepatol·2010
5-case
Complementary regulation of four Eucalyptus CBF genes under various cold conditions.
PMID 19457981·J Exp Bot·2009
8-other
Novel multiple, monoallelic KRAS mutations at codon 12 and 13.
PMID 19521964·Int J Cancer·2009
8-other
Generation of monoclonal antibodies specific for cell surface molecules expressed on early mouse endoderm.
PMID 19522011·Stem Cells·2009
7-preclinical
Site-specific integration of adeno-associated virus involves partial duplication of the target locus.
PMID 19372372·Proc Natl Acad Sci U S A·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2305 DE LA VINA ST
SANTA BARBARA, CA 93105 - Phone
- (805) 687-6408
Quick Facts
- NPI
- 1699961474
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile